Niagen Bioscience Inc (NAGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 17,382 | 8,550 | -4,938 | -16,540 | -27,128 |
| Depreciation Amortization | 785 | 814 | 1,028 | 1,055 | 1,115 |
| Accounts receivable | -756 | -1,279 | 2,255 | -3,319 | -2,578 |
| Accounts payable and accrued liabilities | 2,270 | -1,067 | 553 | -744 | 978 |
| Other Working Capital | -8,296 | 3,134 | 4,562 | -6,318 | -5,010 |
| Other Operating Activity | 2,119 | 1,957 | 3,657 | 10,768 | 8,460 |
| Operating Cash Flow | $13,504 | $12,109 | $7,117 | $-15,098 | $-24,163 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -292 | -143 | -143 | -334 | -409 |
| Investing Cash Flow | $-292 | $-143 | $-143 | $-334 | $-409 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,246 | 5,432 | N/A | 7,747 | 36,235 |
| Common Stock Repurchased | -251 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -79 | -63 | -90 | -93 | -141 |
| Financing Cash Flow | $6,916 | $5,369 | $-90 | $7,654 | $36,094 |
| Beginning Cash Position | 44,660 | 27,325 | 20,441 | 28,219 | 16,697 |
| End Cash Position | 64,788 | 44,660 | 27,325 | 20,441 | 28,219 |
| Net Cash Flow | $20,128 | $17,335 | $6,884 | $-7,778 | $11,522 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13,504 | 12,109 | 7,117 | -15,098 | -24,163 |
| Capital Expenditure | -292 | -163 | -148 | -334 | -409 |
| Free Cash Flow | 13,212 | 11,946 | 6,969 | -15,432 | -24,572 |